ReutersReuters

Polymer Factory Sweden AB Completes Strategic Delivery to Leading Biopharmaceutical Company

RefinitivOkuma süresi: 1 dakika
Polymer Factory

Polymer Factory Sweden AB is pleased to announce the successful completion and shipment of a significant order of dendritic nanomaterials to a leading international biopharmaceutical company specializing in RNA therapeutics. The materials have now been delivered and will support the customer's ongoing RNA-based product development.

Mats Wallnér, CEO of Polymer Factory, commented:

"We are proud to have fulfilled this strategic delivery, which demonstrates both our operational reliability and the strong alignment between our advanced materials and the innovation needs of the RNA therapeutics sector. Our relationship with this customer continues to evolve, and we remain optimistic about deepening our collaboration moving forward."

This delivery marks an important milestone in Polymer Factory's continued expansion into high-impact areas of life science. The company's ability to deliver specialized, high-performance dendritic systems positions it as a trusted partner to leading developers in the field of next-generation therapeutics.

For more information, please contact:

Mats Wallnér, Acting CEO

Phone: +46 (0) 70 951 95 06

E-mail: mats.wallner@polymerfactory.com

Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.

https://news.cision.com/polymer-factory/r/polymer-factory-sweden-ab-completes-strategic-delivery-to-leading-biopharmaceutical-company%2Cc4206296

Release

Bu haberi okumak için giriş yapın veya sonsuza kadar ücretsiz bir hesap oluşturun